142 related articles for article (PubMed ID: 32522522)
1. Ca
Liu W; Le CC; Wang D; Ran D; Wang Y; Zhao H; Gu J; Zou H; Yuan Y; Bian J; Liu Z
Toxicology; 2020 Aug; 441():152520. PubMed ID: 32522522
[TBL] [Abstract][Full Text] [Related]
2. Calcium/calmodulin-dependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL).
Ang ES; Zhang P; Steer JH; Tan JW; Yip K; Zheng MH; Joyce DA; Xu J
J Cell Physiol; 2007 Sep; 212(3):787-95. PubMed ID: 17477372
[TBL] [Abstract][Full Text] [Related]
3. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway.
Sato K; Suematsu A; Nakashima T; Takemoto-Kimura S; Aoki K; Morishita Y; Asahara H; Ohya K; Yamaguchi A; Takai T; Kodama T; Chatila TA; Bito H; Takayanagi H
Nat Med; 2006 Dec; 12(12):1410-6. PubMed ID: 17128269
[TBL] [Abstract][Full Text] [Related]
4. Effect of cadmium on osteoclast differentiation during bone injury in female mice.
He S; Zhuo L; Cao Y; Liu G; Zhao H; Song R; Liu Z
Environ Toxicol; 2020 Apr; 35(4):487-494. PubMed ID: 31793751
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca
Cao B; Dai X; Wang W
J Cell Physiol; 2019 May; 234(5):6831-6841. PubMed ID: 30387123
[TBL] [Abstract][Full Text] [Related]
6. [Effect of zoledronate on protein interaction between Ca(2+)/calmodulin-dependent protein kinaseⅡ and calmodulin and expression of downstream genes during osteoclast differentiation].
Wang H; Dong W; Qi MC; Sun H; Feng XJ; Wen LM
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Feb; 52(2):120-125. PubMed ID: 28253589
[No Abstract] [Full Text] [Related]
7. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotegerin induces podosome disassembly in osteoclasts through calcium, ERK, and p38 MAPK signaling pathways.
Zhao H; Liu X; Zou H; Dai N; Yao L; Gao Q; Liu W; Gu J; Yuan Y; Bian J; Liu Z
Cytokine; 2015 Feb; 71(2):199-206. PubMed ID: 25461399
[TBL] [Abstract][Full Text] [Related]
9. [Influence of zoledronate on osteoclast differentiation and gene expression of calmodulin and calmodulin-dependent protein kinase II].
Li P; Lin JS; Zhang P; Dong W; Li JY; Qi MC
Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Nov; 48(11):694-8. PubMed ID: 24513077
[TBL] [Abstract][Full Text] [Related]
10. Sphingosylphosphorylcholine blocks ovariectomy-induced bone loss by suppressing Ca
Lee HY; Cho KM; Kim MK; Lee M; Kim H; Choi CY; Kim KK; Park JS; Kim HH; Bae YS
J Cell Mol Med; 2021 Jan; 25(1):473-483. PubMed ID: 33230972
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the Ca²⁺ signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation.
Fu Y; Gu J; Wang Y; Yuan Y; Liu X; Bian J; Liu ZP
J Vet Sci; 2015; 16(2):151-6. PubMed ID: 25549213
[TBL] [Abstract][Full Text] [Related]
12. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
13. Adenylate cyclase and calmodulin-dependent kinase have opposite effects on osteoclastogenesis by regulating the PKA-NFATc1 pathway.
Yoon SH; Ryu Jy; Lee Y; Lee ZH; Kim HH
J Bone Miner Res; 2011 Jun; 26(6):1217-29. PubMed ID: 21611964
[TBL] [Abstract][Full Text] [Related]
14. Interplay of calcium and cadmium in mediating cadmium toxicity.
Choong G; Liu Y; Templeton DM
Chem Biol Interact; 2014 Mar; 211():54-65. PubMed ID: 24463198
[TBL] [Abstract][Full Text] [Related]
15. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.
Sankar U; Patel K; Rosol TJ; Ostrowski MC
J Bone Miner Res; 2004 Aug; 19(8):1339-48. PubMed ID: 15231022
[TBL] [Abstract][Full Text] [Related]
16. CaMKⅡ mediates cadmium induced apoptosis in rat primary osteoblasts through MAPK activation and endoplasmic reticulum stress.
Liu W; Xu C; Ran D; Wang Y; Zhao H; Gu J; Liu X; Bian J; Yuan Y; Liu Z
Toxicology; 2018 Aug; 406-407():70-80. PubMed ID: 29883672
[TBL] [Abstract][Full Text] [Related]
17. Tmem64 modulates calcium signaling during RANKL-mediated osteoclast differentiation.
Kim H; Kim T; Jeong BC; Cho IT; Han D; Takegahara N; Negishi-Koga T; Takayanagi H; Lee JH; Sul JY; Prasad V; Lee SH; Choi Y
Cell Metab; 2013 Feb; 17(2):249-60. PubMed ID: 23395171
[TBL] [Abstract][Full Text] [Related]
18. Necrostatin-7 suppresses RANK-NFATc1 signaling and attenuates macrophage to osteoclast differentiation.
Fuji H; Ohmae S; Noma N; Takeiri M; Yasutomi H; Izumi K; Ito M; Toyomoto M; Iwaki S; Takemoto K; Seo S; Taura K; Hida S; Aoyama M; Ishihama Y; Hagiwara M; Takeda N; Hatano E; Iwaisako K; Uemoto S; Asagiri M
Biochem Biophys Res Commun; 2018 Sep; 503(2):544-549. PubMed ID: 29800570
[TBL] [Abstract][Full Text] [Related]
19. Arctigenin suppresses receptor activator of nuclear factor κB ligand (RANKL)-mediated osteoclast differentiation in bone marrow-derived macrophages.
Kim AR; Kim HS; Lee JM; Choi JH; Kim SN; Kim DK; Kim JH; Mun SH; Kim JW; Jeon HS; Kim YM; Choi WS
Eur J Pharmacol; 2012 May; 682(1-3):29-36. PubMed ID: 22387094
[TBL] [Abstract][Full Text] [Related]
20. The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation.
Chang EJ; Ha J; Huang H; Kim HJ; Woo JH; Lee Y; Lee ZH; Kim JH; Kim HH
J Cell Sci; 2008 Aug; 121(Pt 15):2555-64. PubMed ID: 18650497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
